MedPath

ONDANSETRON

ONDANSETRON 4mg

Approved
Approval ID

91e36582-758e-49d2-e053-2995a90a6f7b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 21, 2023

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ONDANSETRON

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-565
Application NumberANDA078539
Product Classification
M
Marketing Category
C73584
G
Generic Name
ONDANSETRON
Product Specifications
Route of AdministrationORAL
Effective DateApril 21, 2023
FDA Product Classification

INGREDIENTS (8)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ONDANSETRON HYDROCHLORIDEActive
Quantity: 4 mg in 1 1
Code: NMH84OZK2B
Classification: ACTIM
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ONDANSETRON - FDA Drug Approval Details